Lankenau Medical Center, Pennsylvania Clinical Trials

A listing of Lankenau Medical Center, Pennsylvania clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 102 clinical trials
A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19

A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of pulsed inhaled iNO compared to placebo in subjects with COVID-19.

pneumonia
nitric oxide
oxygen supplementation
SARS
treatment regimen
Temple University Hospital
 (6.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +13 other locations
Transcranial Magnetic Stimulation and Constraint Induced Language Therapy for Alzheimer Disease

Impaired verbal communication is a cardinal symptom of Alzheimer Disease (AD) and the source of enormous distress and disability. Effective therapies for this deficit are lacking. In light of the emerging literature demonstrating that Transcranial Magnetic Stimulation (TMS) improves general cognition in subjects with Alzheimer Disease (AD), the investigators propose …

mini-mental state examination
deficit
alzheimer's disease
cognitive impairment
University of Pennsylvania
 (4.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
GLS-1200Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19) in Health Care Personnel

This clinical trial will evaluate the safety, tolerability and effectiveness of topical GLS-1200 nasal spray to reduce the incidence of confirmed, symptomatic SARS-CoV-2 infection.

SARS
acute respiratory syndrome (sars)
University of Pennsylvania
 (4.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Tasquinimod for the Treatment of Relapsed or Refractory Myeloma

This study is the first study of tasquinimod, an inhibitor of S100A9, in patients with multiple myeloma.

multiple myeloma
measurable disease
University of Pennsylvania
 (4.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
API Trial-T2

API Trial-T12

Test AP Sit1
 (4.1 away) Contact site
  • 0 views
  • 18 Sep, 2024
  • 1 location
PCSK9i in AAA1236

Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol

Hospital Test1a
 (4.1 away) Contact site
  • 0 views
  • 04 Mar, 2025
  • +1 other locations
PCSK9i in AAA1237

Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol

Hospital Test1a
 (4.1 away) Contact site
  • 0 views
  • 07 May, 2025
  • +1 other locations
PCSK9i in AAA1240

Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol

Hospital Test1a
 (4.1 away) Contact site
  • 0 views
  • 09 May, 2025
  • +1 other locations
PCSK9i in AAA1241

Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol

Hospital Test1a
 (4.1 away) Contact site
  • 0 views
  • 13 May, 2025
  • +1 other locations
IBI3014 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors

This is a phase 1/2 multicenter, multi-regional, open-label, first-in-human study of IBI3014 in participants with unresectable locally advanced or metastatic solid tumors.

Hospital Test1a
 (4.1 away) Contact site
  • 0 views
  • 22 Aug, 2025
  • +1 other locations